N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

C148H153BrClF3N32O11 — CID 157421922

IUPACN-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1Cl.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H](C)CO)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(Nc4ccnn4C)cc3n2)c2cnn(C)c2)cc1F.O=C(NCCc1ccccc1Br)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C27H28ClN5O2.C27H28FN5O2.C25H23FN8O.C24H25FN6O2.C23H26N4O2.C22H23BrN4O2/c2*1-17-3-4-19(14-22(17)28)26(25-7-10-30-33(25)2)32-27(34)23-6-5-20-16-29-21(15-24(20)31-23)13-18-8-11-35-12-9-18;1-15-4-5-16(10-19(15)26)24(18-13-29-33(2)14-18)32-25(35)20-7-6-17-12-27-22(11-21(17)30-20)31-23-8-9-28-34(23)3;1-14-4-5-16(8-19(14)25)23(18-11-27-31(3)12-18)30-24(33)20-7-6-17-10-26-22(9-21(17)29-20)28-15(2)13-32;1-16-2-4-17(5-3-16)8-11-24-23(28)20-7-6-18-15-25-22(14-21(18)27-20)26-19-9-12-29-13-10-19;23-18-4-2-1-3-15(18)7-10-24-22(28)19-6-5-16-14-25-21(13-20(16)27-19)26-17-8-11-29-12-9-17/h2*3-7,10,14-16,18,26H,8-9,11-13H2,1-2H3,(H,32,34);4-14,24H,1-3H3,(H,27,31)(H,32,35);4-12,15,23,32H,13H2,1-3H3,(H,26,28)(H,30,33);2-7,14-15,19H,8-13H2,1H3,(H,24,28)(H,25,26);1-6,13-14,17H,7-12H2,(H,24,28)(H,25,26)/t2*26-;24-;15-,23-;;/m0000../s1
InChIKeyBPMXCBUHVNJHOU-HSCATXEWSA-N
MW2728.42 g/mol
LogP23.50
Rot. Bonds37

About N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (PubChem CID 157421922) has the molecular formula C148H153BrClF3N32O11 and a molecular weight of 2728.42 g/mol. Its IUPAC name is N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
PubChem CID157421922
Molecular FormulaC148H153BrClF3N32O11
Molecular Weight2728.42 g/mol
Exact Mass2725.12
IUPAC NameN-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1Cl.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H](C)CO)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(Nc4ccnn4C)cc3n2)c2cnn(C)c2)cc1F.O=C(NCCc1ccccc1Br)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C27H28ClN5O2.C27H28FN5O2.C25H23FN8O.C24H25FN6O2.C23H26N4O2.C22H23BrN4O2/c2*1-17-3-4-19(14-22(17)28)26(25-7-10-30-33(25)2)32-27(34)23-6-5-20-16-29-21(15-24(20)31-23)13-18-8-11-35-12-9-18;1-15-4-5-16(10-19(15)26)24(18-13-29-33(2)14-18)32-25(35)20-7-6-17-12-27-22(11-21(17)30-20)31-23-8-9-28-34(23)3;1-14-4-5-16(8-19(14)25)23(18-11-27-31(3)12-18)30-24(33)20-7-6-17-10-26-22(9-21(17)29-20)28-15(2)13-32;1-16-2-4-17(5-3-16)8-11-24-23(28)20-7-6-18-15-25-22(14-21(18)27-20)26-19-9-12-29-13-10-19;23-18-4-2-1-3-15(18)7-10-24-22(28)19-6-5-16-14-25-21(13-20(16)27-19)26-17-8-11-29-12-9-17/h2*3-7,10,14-16,18,26H,8-9,11-13H2,1-2H3,(H,32,34);4-14,24H,1-3H3,(H,27,31)(H,32,35);4-12,15,23,32H,13H2,1-3H3,(H,26,28)(H,30,33);2-7,14-15,19H,8-13H2,1H3,(H,24,28)(H,25,26);1-6,13-14,17H,7-12H2,(H,24,28)(H,25,26)/t2*26-;24-;15-,23-;;/m0000../s1
InChIKeyBPMXCBUHVNJHOU-HSCATXEWSA-N
XLogP23.50
TPSA523.65 Ų
H-Bond Donors11
H-Bond Acceptors37
Rotatable Bonds37
Heavy Atoms196
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002728.42
LogP ≤ 523.50
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1037

Analyze N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 157183034
CID 157183034
CID 158901147
CID 158901147
CID 160034525
CID 160034525
CID 160486142
CID 160486142
CID 161211566
CID 161211566

Frequently Asked Questions

What is the IUPAC name of N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The IUPAC name of N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (CID 157421922) is N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.
What is the SMILES notation for N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The canonical SMILES for N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is Cc1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1Cl.Cc1ccc([C@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2ccnn2C)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H](C)CO)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(Nc4ccnn4C)cc3n2)c2cnn(C)c2)cc1F.O=C(NCCc1ccccc1Br)c1ccc2cnc(NC3CCOCC3)cc2n1.
What is the InChIKey of N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The InChIKey is BPMXCBUHVNJHOU-HSCATXEWSA-N. The full InChI is InChI=1S/C27H28ClN5O2.C27H28FN5O2.C25H23FN8O.C24H25FN6O2.C23H26N4O2.C22H23BrN4O2/c2*1-17-3-4-19(14-22(17)28)26(25-7-10-30-33(25)2)32-27(34)23-6-5-20-16-29-21(15-24(20)31-23)13-18-8-11-35-12-9-18;1-15-4-5-16(10-19(15)26)24(18-13-29-33(2)14-18)32-25(35)20-7-6-17-12-27-22(11-21(17)30-20)31-23-8-9-28-34(23)3;1-14-4-5-16(8-19(14)25)23(18-11-27-31(3)12-18)30-24(33)20-7-6-17-10-26-22(9-21(17)29-20)28-15(2)13-32;1-16-2-4-17(5-3-16)8-11-24-23(28)20-7-6-18-15-25-22(14-21(18)27-20)26-19-9-12-29-13-10-19;23-18-4-2-1-3-15(18)7-10-24-22(28)19-6-5-16-14-25-21(13-20(16)27-19)26-17-8-11-29-12-9-17/h2*3-7,10,14-16,18,26H,8-9,11-13H2,1-2H3,(H,32,34);4-14,24H,1-3H3,(H,27,31)(H,32,35);4-12,15,23,32H,13H2,1-3H3,(H,26,28)(H,30,33);2-7,14-15,19H,8-13H2,1H3,(H,24,28)(H,25,26);1-6,13-14,17H,7-12H2,(H,24,28)(H,25,26)/t2*26-;24-;15-,23-;;/m0000../s1.
What are the key properties of N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide has a molecular weight of 2728.42 g/mol, XLogP of 23.50, 37 rotatable bonds, 11 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(2-bromophenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-chloro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(2S)-1-hydroxypropan-2-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[(2-methylpyrazol-3-yl)amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;N-[2-(4-methylphenyl)ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is sourced from PubChem (CID 157421922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).